Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 26 - 49 of 49 in total
AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.
Investigational
Matched Name: … AZD-0424 …
Azd8418 is under investigation in clinical trial NCT01027234 (This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses).
Investigational
Matched Name: … AZD-8418 …
AZD-1656 is under investigation in clinical trial NCT00747175 (A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes).
Investigational
Matched Name: … AZD-1656 …
Matched Description: … AZD-1656 is under investigation in clinical trial NCT00747175 (A Study to Evaluate Safety, Tolerability …
AZD-8848 is under investigation in clinical trial NCT01818869 (To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects).
Investigational
Matched Name: … AZD-8848 …
Matched Description: … AZD-8848 is under investigation in clinical trial NCT01818869 (To Assess the Safety, Tolerability, Pharmacokinetics …
AZD-8186 is under investigation in clinical trial NCT03218826 (PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery).
Investigational
Matched Name: … AZD-8186 …
Matched Description: … AZD-8186 is under investigation in clinical trial NCT03218826 (PI3Kbeta Inhibitor AZD8186 and Docetaxel …
AZD-9496 is under investigation in clinical trial NCT02248090 (AZD9496 First Time in Patients Ascending Dose Study).
Investigational
Matched Name: … AZD-9496 …
Matched Description: … AZD-9496 is under investigation in clinical trial NCT02248090 (AZD9496 First Time in Patients Ascending …
Investigational
Matched Name: … AZD-5153 …
AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. It is developed by AstraZeneca and is currently in phase I/II trials.
Investigational
Matched Name: … AZD 3355 …
Matched Description: … AZD 3355 is a reflux inhibitor used for the treatment of Gastroesophageal Reflux Disease. …
AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.
Investigational
Matched Name: … AZD-9684 …
Matched Description: … AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). …
AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways implicated in cancer cell proliferation and survival. AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including melanoma, pancreatic, colon, lung, and breast cancers.
Investigational
Matched Name: … AZD-8330 …
Matched Description: … AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways ... AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including …
AZD1305 has been used in trials studying the treatment and basic science of Atrial Flutter, Atrial Fibrillation, and Left Ventricle Function.
Investigational
Matched Name: … AZD-1305 …
Azd5672 has been used in trials studying the basic science and treatment of Pharmacokinetics, Renal Impairment, and Rheumatoid Arthritis.
Investigational
Matched Name: … AZD-5672 …
AZD9164 has been used in trials studying the basic science and treatment of Chronic Obstructive Pulmonary Disease.
Investigational
Matched Name: … AZD-9164 …
AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.
Investigational
Matched Name: … AZD-0328 …
AZD6280 has been used in trials studying the basic science of Anxiety.
Investigational
Matched Name: … AZD-6280 …
AZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.
Investigational
Matched Name: … AZD-7762 …
AZD5423 has been used in trials studying the basic science and treatment of Asthma, Bioavailability and AUC, and Chronic Obstructive Pulmonary Disease (COPD).
Investigational
Matched Name: … AZD-5423 …
AZD2066 has been used in trials studying the treatment and basic science of Pain, Chronic Pain, Reflux Episodes, Neuropathic Pain, and Diabetic Neuropathy, among others.
Investigational
Matched Name: … AZD-2066 …
AZD7295 has been investigated for the treatment of Hepatitis C.
Investigational
Matched Name: … AZD-7295 …
AZD7325 is a high affinity, selective modulator of the GABAA receptor system.
Investigational
Matched Name: … AZD-7325 …
AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.).
Investigational
Matched Name: … AZD-5991 …
Matched Description: … AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory …
AZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure).
Investigational
Matched Name: … AZD-4017 …
Matched Description: … AZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability …
AZD-9977 is under investigation in clinical trial NCT03843060 (A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers).
Investigational
Matched Name: … AZD-9977 …
Matched Description: … AZD-9977 is under investigation in clinical trial NCT03843060 (A Phase 1 Study to Assess the Pharmacokinetics …
Investigational
Matched Name: … AZD-1940 …
Displaying drugs 26 - 49 of 49 in total